The purpose of the study is to compare two fixed dose combination tablets of dapagliflozin/metformin XR in healthy subjects under fasting and fed conditions

Trial Identifier: D1691C00016
Sponsor: AstraZeneca
NCTID:: NCT03216278
Start Date: September 2017
Primary Completion Date: May 2018
Study Completion Date: May 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Portugese Translation

Trial Locations

Country Location
Brazil Aparecida de Goiania, Brazil, 74935-530